SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001214659-24-002856
Filing Date
2024-02-14
Accepted
2024-02-14 16:00:26
Documents
1
Group Members
KEVIN TANGTANG CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 b110242sc13ga1.htm SC 13G/A 82803
  Complete submission text file 0001214659-24-002856.txt   84463
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL PARTNERS LP (Filed by) CIK: 0001191935 (see all company filings)

IRS No.: 680517277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89137 | Film No.: 24637383
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)